Sudeep Pharma Limited (SUDEEPPHRM) — Announcement
Sudeep Pharma Limited disclosed a mandatory acquisition announcement under SEBI Takeover Regulations on April 8, 2026. The filing involves a potential change in control or substantial stake acquisition, triggering regulatory disclosure requirements. Specific acquisition details, consideration amount, and acquirer identity were not explicitly stated in this regulatory notice. Shareholders should monitor subsequent filings for complete transaction terms and timeline.
About Sudeep Pharma Limited (SUDEEPPHRM)
Chemicals · Chemicals & Petrochemicals · Listed on NSE
📡 Get AI alerts when SUDEEPPHRM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUDEEPPHRM — Free💡 Ask AI about this filing
📊 More SUDEEPPHRM filings
- 🔴 Corporate Action — 10 July 2026 Sudeep Pharma announced a final dividend of ₹1.50 per share for FY 2025-26, with the record date set...
- 🟡 Board Meeting — 26 June 2026 Sudeep Pharma announced the appointment of Mr. Milin Mehta as a Non-Executive Non-Independent Direct...
- 🟡 Board Meeting — 26 June 2026 Sudeep Pharma announced the appointment of Mr. Milin Mehta as an additional non-executive non-indepe...
- Announcement — 21 May 2026 Sudeep Pharma Limited reported FY26 revenue of **₹642.3 crores**, up 16% YoY, with PAT rising to **₹...
- 🔴 Corporate Action — 21 May 2026 Sudeep Pharma Limited announced a final dividend of Rs 1.50 per share (150% of face value) for FY202...
🔥 Also filed on 8 April 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SUDEEPPHRM files new disclosures
Track SUDEEPPHRM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUDEEPPHRM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research